The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

CYCN Insider Trading (Cyclerion Therapeutics)

Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $5,999,993.52
Insider Selling (Last 12 Months): $0.00

Cyclerion Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cyclerion Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cyclerion Therapeutics Share Price & Price History

Current Price: $0.57
Price Change: Price Decrease of -0.0185 (-3.17%)
As of 05/13/2022 07:55 PM ET

This chart shows the closing price history over time for CYCN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Warning: The Last Value Play Gone After August?
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.
Get the Details Now.

Cyclerion Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2021Peter M. HechtCEOBuy823,170$3.28$2,699,997.602,047,698View SEC Filing Icon  
6/3/2021Slate Path Capital LpMajor ShareholderBuy961,538$3.12$2,999,998.56View SEC Filing Icon  
6/3/2021Terrance McguireDirectorBuy96,153$3.12$299,997.3611,047View SEC Filing Icon  
5/6/2021Peter M. HechtCEOBuy302,000$2.43$733,860.001,224,528View SEC Filing Icon  
5/4/2021Peter M. HechtCEOBuy300,000$2.29$687,000.00524,527View SEC Filing Icon  
12/28/2020Mark G CurrieInsiderSell20,107$3.01$60,522.07251,648View SEC Filing Icon  
11/9/2020Andreas BuschInsiderBuy125,000$2.53$316,250.00View SEC Filing Icon  
11/6/2020William HuyettCFOSell3,827$2.52$9,644.0467,590View SEC Filing Icon  
12/30/2019Mark G CurriePresidentSell25,000$2.48$62,000.00296,755View SEC Filing Icon  
12/27/2019Mark G CurriePresidentSell25,000$2.55$63,750.00296,755View SEC Filing Icon  
11/15/2019Andreas BuschInsiderBuy125,000$1.82$227,500.00125,000View SEC Filing Icon  
11/8/2019William HuyettCFOSell3,922$2.05$8,040.1074,976View SEC Filing Icon  
See Full Table
Bargain in Today's Market (SHOCKING)
This "World's Most Admired" company's stock would be a bargain at $50...Today it's just $2! Plus... a key May 12 announcement could send it ROCKETING skyward...

Click Here Now (Before It's Too Late!)
>>>

SEC Filings (Institutional Ownership Changes) for Cyclerion Therapeutics (NASDAQ:CYCN)

54.51% of Cyclerion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CYCN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cyclerion Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC302,558$0.34M0.0%-12.5%0.696%Search for SEC Filing on Google Icon
5/13/2022Mackenzie Financial Corp25,309$28K0.0%N/A0.058%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.1,754,153$1.95M0.0%-6.2%4.037%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP45,058$50K0.0%-63.0%0.104%Search for SEC Filing on Google Icon
5/12/2022Acadian Asset Management LLC231,952$0.26M0.0%-7.1%0.534%Search for SEC Filing on Google Icon
5/9/2022Trustcore Financial Services LLC292,645$0.33M0.0%+47.7%0.674%Search for SEC Filing on Google Icon
3/3/2022Walleye Capital LLC25,345$44K0.0%N/A0.058%Search for SEC Filing on Google Icon
2/15/2022Millennium Management LLC249,656$0.43M0.0%-17.1%0.576%Search for SEC Filing on Google Icon
2/14/2022D. E. Shaw & Co. Inc.136,609$0.24M0.0%-49.9%0.315%Search for SEC Filing on Google Icon
2/14/2022State Street Corp110,821$0.19M0.0%+23.5%0.256%Search for SEC Filing on Google Icon
2/14/2022Diametric Capital LP100,480$0.17M0.1%+43.9%0.232%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC565,835$0.97M0.0%+15.3%1.306%Search for SEC Filing on Google Icon
2/11/2022Renaissance Technologies LLC345,900$0.60M0.0%+378.4%0.799%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC249,792$0.43M0.0%N/A0.577%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP121,867$0.21M0.0%-11.7%0.281%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp80,792$0.14M0.0%+12.4%0.187%Search for SEC Filing on Google Icon
11/16/2021Jane Street Group LLC16,607$51K0.0%N/A0.038%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP647,700$1.99M0.0%+98.4%1.495%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP390,596$1.20M0.0%+154.1%0.902%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC301,126$0.92M0.0%-22.6%0.695%Search for SEC Filing on Google Icon
11/15/2021Pura Vida Investments LLC422,311$1.30M0.0%-16.8%0.975%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley74,508$0.23M0.0%+6.2%0.172%Search for SEC Filing on Google Icon
11/15/2021Eversept Partners LP371,955$1.14M0.1%N/A0.859%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP137,959$0.42M0.0%-13.2%0.318%Search for SEC Filing on Google Icon
11/15/2021Franklin Resources Inc.116,035$0.36M0.0%N/A0.268%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC72,300$0.22M0.0%-74.6%0.167%Search for SEC Filing on Google Icon
11/12/2021Jump Financial LLC52,000$0.16M0.0%N/A0.120%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC490,660$1.51M0.0%+27.5%1.134%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.43,903$0.14M0.0%+20.9%0.101%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC80,384$0.31M0.0%-9.2%0.186%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC12,596$49K0.0%-52.0%0.029%Search for SEC Filing on Google Icon
8/25/2021Marshall Wace LLP28,863$0.11M0.0%N/A0.067%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley70,155$0.27M0.0%+85.7%0.162%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC509,924$1.99M0.2%+70.0%1.178%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC389,041$1.52M0.0%N/A0.899%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC66,977$0.26M0.0%+96.3%0.155%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC17,084$67K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley70,155$0.27M0.0%+85.7%0.162%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP80,336$0.31M0.2%N/A0.186%Search for SEC Filing on Google Icon
8/16/2021Slate Path Capital LP7,157,601$27.92M1.6%+15.5%16.539%Search for SEC Filing on Google Icon
8/16/2021Charles Schwab Investment Management Inc.129,628$0.51M0.0%-35.1%0.300%Search for SEC Filing on Google Icon
8/16/2021State Street Corp83,321$0.33M0.0%-79.2%0.193%Search for SEC Filing on Google Icon
8/16/2021Tibra Equities Europe Ltd85,000$0.33M0.1%N/A0.196%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.36,317$0.14M0.0%-9.4%0.084%Search for SEC Filing on Google Icon
8/16/2021Marshall Wace LLP28,863$0.11M0.0%N/A0.067%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC284,744$1.11M0.0%+22.1%0.658%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp64,616$0.25M0.0%-73.0%0.149%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC384,820$1.50M0.0%-21.0%0.889%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.1,423,532$5.55M0.0%-14.7%3.289%Search for SEC Filing on Google Icon
8/13/2021FMR LLC2,674,811$10.43M0.0%-1.9%6.181%Search for SEC Filing on Google Icon
8/12/2021Prime Capital Investment Advisors LLC22,250$87K0.0%N/A0.051%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd17,968$70K0.0%+34.4%0.042%Search for SEC Filing on Google Icon
8/12/2021Dimensional Fund Advisors LP158,994$0.62M0.0%+160.1%0.367%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.59,786$0.23M0.0%-43.7%0.138%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC96,100$0.38M0.0%N/A0.222%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp66,792$0.26M0.0%-31.9%0.154%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG65,900$0.26M0.0%-18.7%0.152%Search for SEC Filing on Google Icon
8/11/2021Susquehanna Fundamental Investments LLC105,572$0.41M0.0%N/A0.244%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC88,551$0.25M0.0%N/A0.259%Search for SEC Filing on Google Icon
5/18/2021D. E. Shaw & Co. Inc.68,472$0.19M0.0%-62.2%0.201%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley37,781$0.11M0.0%-90.9%0.111%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC42,900$0.12M0.0%+74.4%0.126%Search for SEC Filing on Google Icon
5/17/2021Walleye Trading LLC10,000$28K0.0%N/A0.029%Search for SEC Filing on Google Icon
5/17/2021Walleye Capital LLC15,000$42K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC300,000$0.84M0.0%N/A0.879%Search for SEC Filing on Google Icon
5/14/2021XTX Topco Ltd13,365$37K0.0%N/A0.039%Search for SEC Filing on Google Icon
5/13/2021QS Investors LLC116,035$0.32M0.0%+13.1%0.340%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC18,516$52K0.0%+159.0%0.054%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC233,200$0.65M0.0%+1,202.8%0.683%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp239,015$0.67M0.0%-7.0%0.700%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC486,959$1.36M0.0%+12.2%1.427%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.106,102$0.30M0.0%+19.1%0.311%Search for SEC Filing on Google Icon
5/11/2021New York State Common Retirement Fund12,070$34K0.0%-91.0%0.035%Search for SEC Filing on Google Icon
5/10/2021Russell Investments Group Ltd.124,075$0.35M0.0%+400.2%0.363%Search for SEC Filing on Google Icon
5/10/2021Bank Julius Baer & Co. Ltd Zurich12,000$33K0.0%-33.2%0.035%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.1,685,485$4.70M0.0%+5.1%4.938%Search for SEC Filing on Google Icon
4/28/2021DAVENPORT & Co LLC84,500$0.24M0.0%+369.0%0.248%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP63,735$0.20M0.0%+8.7%0.187%Search for SEC Filing on Google Icon
3/1/2021UBS Asset Management Americas Inc.10,149$31K0.0%-58.8%0.030%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP63,735$0.20M0.0%+8.7%0.188%Search for SEC Filing on Google Icon
2/24/2021Bank Julius Baer & Co. Ltd Zurich17,974$55K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/19/2021JPMorgan Chase & Co.89,079$0.27M0.0%+84.8%0.262%Search for SEC Filing on Google Icon
2/16/2021Charles Schwab Investment Management Inc.177,091$0.54M0.0%-6.5%0.521%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp257,044$0.79M0.0%-3.4%0.757%Search for SEC Filing on Google Icon
2/10/2021Rhumbline Advisers34,065$0.10M0.0%+15.8%0.100%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC17,900$55K0.0%N/A0.053%Search for SEC Filing on Google Icon
2/10/2021QS Investors LLC102,600$0.31M0.0%N/A0.302%Search for SEC Filing on Google Icon
2/9/2021Wells Fargo & Company MN50,522$0.15M0.0%+77.9%0.149%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp100,061$0.31M0.0%+13.2%0.295%Search for SEC Filing on Google Icon
2/8/2021Alliancebernstein L.P.31,800$97K0.0%-6.5%0.094%Search for SEC Filing on Google Icon
2/8/2021NorthRock Partners LLC10,000$31K0.0%N/A0.029%Search for SEC Filing on Google Icon
2/8/2021New York State Common Retirement Fund133,709$0.41M0.0%-5.8%0.394%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.1,604,118$4.91M0.0%+5.3%4.723%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP23,335$71K0.0%N/A0.069%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC10,312$63K0.0%N/A0.030%Search for SEC Filing on Google Icon
11/17/2020California State Teachers Retirement System33,518$0.20M0.0%-9.9%0.099%Search for SEC Filing on Google Icon
11/16/2020ExodusPoint Capital Management LP17,330$0.11M0.0%N/A0.051%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley62,364$0.38M0.0%+672.0%0.184%Search for SEC Filing on Google Icon
11/13/2020Charles Schwab Investment Management Inc.189,413$1.15M0.0%+46.0%0.558%Search for SEC Filing on Google Icon
11/12/2020JPMorgan Chase & Co.48,196$0.33M0.0%+541.2%0.142%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cyclerion Therapeutics logo
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, as well as Alzheimer's disease with vascular pathology; and Phase 1 trials diagnosed with schizophrenia in adults. It is also developing Praliciguat, an orally administered systemic sGC stimulator, which is in Phase II studies to treat resistant hypertension and diabetic nephropathy; Olinciguat, an orally administered vascular sGC stimulator that is in Phase II studies for the sickle cell disease; and CY3018 for the treatment of disorders of the CNS. It has license agreement with Akebia Therapeutics, Inc. for the development, manufacture, medical affairs, and commercialization of pharmaceutical products, including pharmaceutical compound, and other related products and forms. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Read More on Cyclerion Therapeutics

Today's Range

Now: $0.57
Low: $0.55
High: $0.58

50 Day Range

MA: $0.95
Low: $0.55
High: $1.29

52 Week Range

Now: $0.57
Low: $0.50
High: $4.86

Volume

177,700 shs

Average Volume

142,618 shs

Market Capitalization

$24.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.94

Who are the company insiders with the largest holdings of Cyclerion Therapeutics?

Cyclerion Therapeutics' top insider shareholders include:
  1. Peter M Hecht (CEO)
  2. Peter M Hecht (CEO)
  3. Mark G Currie (Insider)
  4. William Huyett (CFO)
  5. Terrance Mcguire (Director)
  6. Andreas Busch (Insider)
  7. Slate Path Capital Lp (Major Shareholder)
Learn More about top insider investors at Cyclerion Therapeutics.

Who are the major institutional investors of Cyclerion Therapeutics?

Cyclerion Therapeutics' top institutional investors include:
  1. Vanguard Group Inc. — 4.04%
  2. Renaissance Technologies LLC — 0.70%
  3. Trustcore Financial Services LLC — 0.67%
  4. Acadian Asset Management LLC — 0.53%
  5. Dimensional Fund Advisors LP — 0.10%
  6. Mackenzie Financial Corp — 0.06%
Learn More about top institutional investors of Cyclerion Therapeutics stock.

Which major investors are selling Cyclerion Therapeutics stock?

During the last quarter, CYCN stock was sold by these institutional investors:
  1. Vanguard Group Inc.
  2. Dimensional Fund Advisors LP
  3. Renaissance Technologies LLC
  4. Acadian Asset Management LLC
  5. Group One Trading L.P.
  6. Simplex Trading LLC

Which major investors are buying Cyclerion Therapeutics stock?

During the last quarter, CYCN stock was purchased by institutional investors including:
  1. Trustcore Financial Services LLC
  2. Mackenzie Financial Corp
Within the last year, these company insiders have bought Cyclerion Therapeutics stock:
  1. Peter M Hecht (CEO)
  2. Peter M Hecht (CEO)
  3. Mark G Currie (Insider)
  4. William Huyett (CFO)
  5. Terrance Mcguire (Director)
Learn More investors buying Cyclerion Therapeutics stock.
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!